MIR4738: A Potential Drug Target and Biomarker for Obesity (G100616282)
MIR4738: A Potential Drug Target and Biomarker for Obesity
Obesity is a significant public health issue, with over 20% of adults worldwide classified as obese or overweight. The consequences of obesity are numerous, including increased risk of cardiovascular disease, diabetes, and certain cancers. MIR4738, a protein that has been identified as a potential drug target and biomarker for obesity, is a focus of interest for those looking to develop new treatments for this debilitating condition.
MIR4738 is a non-coding RNA molecule that has been shown to play a critical role in the regulation of energy metabolism and adiposity. It is located in the nucleus and is known to interact with various protein partners, including the transcription factor, PPAR未. MIR4738 has been shown to regulate the expression of genes involved in energy metabolism, inflammation, and cellular processes that are linked to obesity.
In addition to its role in obesity, MIR4738 has also been linked to the development of type 2 diabetes. Type 2 diabetes is a major risk factor for cardiovascular disease and is associated with an increased risk of obesity. MIR4738 has been shown to be involved in the regulation of insulin sensitivity and glucose metabolism, which are critical for the development and progression of type 2 diabetes.
The potential drug target for MIR4738 is related to the modulation of energy metabolism and the regulation of body weight. Drugs that target MIR4738 have the potential to reduce body weight and improve energy metabolism, which can be beneficial for weight management and overall health.
MIR4738 has also been shown to be involved in the regulation of inflammation. Obesity is often associated with an increased risk of inflammation in the body, which can contribute to the development of various diseases, including cardiovascular disease and diabetes. MIR4738 has been shown to be involved in the regulation of pro-inflammatory pathways and has been shown to have anti-inflammatory effects.
The potential drug target for MIR4738 is also related to the regulation of cellular processes that are linked to the development of cancer. Obesity is often associated with an increased risk of cancer, including breast, ovarian, and prostate cancer. MIR4738 has been shown to be involved in the regulation of cellular processes that are linked to the development of cancer, including cell growth, apoptosis, and angiogenesis.
In conclusion, MIR4738 is a protein that has been identified as a potential drug target and biomarker for obesity. Its role in the regulation of energy metabolism, inflammation, and cellular processes that are linked to obesity makes it an attractive target for drug development. Further research is needed to fully understand the potential drug targets and biomarkers for MIR4738, as well as the development of new treatments for obesity.
Protein Name: MicroRNA 4738
The "MIR4738 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4738 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR4739 | MIR4740 | MIR4741 | MIR4742 | MIR4745 | MIR4746 | MIR4747 | MIR4749 | MIR4750 | MIR4751 | MIR4752 | MIR4753 | MIR4754 | MIR4755 | MIR4756 | MIR4757 | MIR4758 | MIR4759 | MIR4760 | MIR4761 | MIR4762 | MIR4763 | MIR4764 | MIR4765 | MIR4766 | MIR4767 | MIR4768 | MIR4769 | MIR4770 | MIR4771-1 | MIR4771-2 | MIR4772 | MIR4773-1 | MIR4773-2 | MIR4774 | MIR4775 | MIR4776-1 | MIR4776-2 | MIR4777 | MIR4778 | MIR4779 | MIR4780 | MIR4781 | MIR4782 | MIR4783 | MIR4784 | MIR4785 | MIR4786 | MIR4787 | MIR4789 | MIR4790 | MIR4791 | MIR4793 | MIR4794 | MIR4795 | MIR4796 | MIR4797 | MIR4798 | MIR4799 | MIR4800 | MIR4802 | MIR4803 | MIR4804 | MIR483 | MIR484 | MIR485 | MIR486-1 | MIR486-2 | MIR487A | MIR487B | MIR488 | MIR489 | MIR490 | MIR491 | MIR492 | MIR493 | MIR494 | MIR495 | MIR496 | MIR497 | MIR497HG | MIR498 | MIR4999 | MIR499A | MIR499B | MIR5000 | MIR5001 | MIR5002 | MIR5003 | MIR5004 | MIR5006 | MIR5007 | MIR5008 | MIR5009 | MIR500A | MIR500B | MIR501 | MIR5010 | MIR5011 | MIR502
